异倍体

结论：DNA异倍体提示前列腺肿瘤的发生。

Conclusion : DNA heteroploid implies the emergence of prostate cancer .

DNA异倍体与淋巴结有无转移之间存在显著性差异（P0.05）。

DNA heteroploid was significantly correlated with LN metastasis ( P0.05 ) .

DNA异倍体与肝癌肝内转移及合并癌栓有关。

Aneuploid DNA content was related with liver metastasis and cancerous thrombosis .

结果：良性肿瘤组未检出DNA异倍体；

Results : DNA Diploid were detected in benign tumors ;

26例（61.90%）为DNA干系异倍体肿瘤。

26 ( 61.90 % ) cases were DNA abnormal stemline tumor .

恶性腹水检测DNA异倍体的临床意义

The Clinical Significance on the Detection of DNA Aneuploid in Malignant Ascites

结论：DNA异倍体的出现可以认为是癌变的标志，临界瘤中检出DNA异倍体预示有癌变倾向。

Conclusion : DNA aneuploid is the mark of malignancy ;

临界瘤中检出DNA异倍体预示有癌变倾向。

DNA aneuploid detected in premalignant tumor suggests malignant trend .

结论DNA异倍体的检出是恶性肿瘤的重要特征之一；

Conclusions DNA aneuploid is the mark of malignancy ;

DNA异倍体的检出率为21.9%。

Aneuploidy was 21.7 % in ANLL .

联检端粒酶活性和DNA异倍体诊断恶性腹水

Combined Determination of Telomerase Activity and DNA Aneuploid in Ascites for Diagnosis of Malignant Ascites

结论：DNA异倍体与急性淋巴细胞白血病的预后有关；

Conclusion : DNA aneuploid , cell cycle are of significance on the judgement of prognosis .

各例均作流式细胞DNA异倍体检测与癌胚抗原测定。

All the patients'pleural effusion was detected by the DNA heteroploid detection with flow cytometry and CEA detection .

检测端粒酶活性和DNA异倍体对恶性腹水诊断价值

Application value of the detection of telomerase activity and DNA aneuploid in ascites for the diagnosis of malignant ascites

结果在恶性骨肿瘤中多数为DNA异倍体，各类恶性骨肿瘤之间FI、DI、PI值差异无显著性意义（P＞0.05）。

Results Majority of malignant bone tumor are aneuploid .

结果良性胸水DNA异倍体率仅占23.1%。

Results : The rates of aneuploid in benign and malignant pleural fluids were 23.1 % and 77.8 % , respectively .

研究显示，流式细胞术DNA倍体分析可以在92%的实体肿瘤上检测到DNA异倍体的存在。

Researches have shown that flow cytometric DNA analysis can detect DNA aneuploidy in as much as 92 % of tumors .

本实验发现含有不典型增生的结节性甲状腺肿细胞DNA指数、异倍体发生率显著高于正常对照组织和无不典型增生的甲状腺肿细胞；

In our data , the cellular DNA index and heteroploid frequency of multinodular goiter patients with atypical hyperplasia distinctly increased .

结果：DNA组方图呈二倍体的肿瘤14例，异倍体的肿瘤48例（检出率77.4%）；

Results DNA histograms showed DNA diploidy in 14 cases , aneuploidy in 48 cases ( the detectability 77 42 % ) .

癌组织的异倍体表达率（57.7%）及PI值与其癌旁组织均有显著性差异（P＜0.05），bcl－2表达在癌组织及其癌旁组织间无显著性差异（P＞0.05）。

Bcl 2 expression has no significant difference between cancer tissue and para cancer tissue ( P < 0.05 ) .

淋巴结转移及DNA异倍体组CD44v5/v6阳性表达率明显高于无转移组及DNA二倍体组（P<0.01）；

It was significantly higher in patients with lymph node metastasis or DNA aneuploid compared to those without metastasis ( P < 0.01 ) .

VIP、CEA阳性标本大多数为异倍体（16／20，9／11），这些异倍体均表现为非整倍体。

Tumors with expression of VIP and CEA were mostly aneuploid .

结论：DNA异倍体的发生、SPF值、EGFR阳性率与胶质瘤恶性级别正相关。

Conclusion DNA aneuploidy , SPF and EGFR is associated with malignant degree of gliomas .

良性涎腺多形性腺瘤DNA二倍体率为84%（42例），异倍体率16%（8例）；

Results The FCM DNA diploid rate of the benign pleomorphic adenomas of salivary gland was 84 % , and aneuploidy rate was 16 % .

结果：80·43%（37/46）的标本中发现X和（或）Y染色体异倍体，主要特征为X染色体增多和Y染色体丢失。

RESULTS : Aeulpoidy , mainly featured in gains of chromosomal X and loss of chromosome Y were observed in80.43 % of46 cases .

目的了解小儿急性白血病（AL）的免疫表型、异倍体、细胞周期分布状况及其之间的关系。

Objective To investigated the immunophenotype , aneuploid , cell circle distribution and their relationships in children 's acute leukemia ( AL ) .

结论流式细胞术分析胸腔积液及腹水细胞的DNA异倍体，对于恶性肿瘤的细胞学诊断有重大意义。

Conclusion The analysis of the DNA aneuploid in the pleural fluid and the ascites by flow cytometry provided the valuable cytodiagnosis for the malignant tumors .

溃疡型中的DNA异倍体出现率为56.5%，显著高于隆起型（14.7%）（P<0.01）。

Aneuploidy was detected at 56.5 % in ulcerating carcinoma , which was significantly higher than 14.7 % in bulge carcinoma ( P < 0.01 ) .

胸水流式细胞DNA异倍体诊断的敏感性为80.5%、特异性90%、准确性85.2%；

The sensitivity of the DNA heteroploid detection with flow cytometry was 80.5 % , the specificity was 90 % and the accuracy was 85.2 % .

DNA异倍体联合C-12检测在良恶性腹水中的诊断价值

Diagnostic Values of DNA-aneuploidy and C-12 Analysis for Benign and Malignant Ascites